The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Non-Hodgkin lymphoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationCancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8800 · Cited by 5,715
Self-citationCoiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Report of the Committee on Hodgkin's Disease Staging Classification.
Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W., & Tubiana, M. (1971) · PubMed · Cited by 4,166
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Self-citationMcLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2825 · Cited by 2,755
The Non-Hodgkin's Lymphoma Classification Project (1997) · Blood · doi:10.1182/blood.v89.11.3909 · Cited by 2,461
Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.-Y., Harousseau, J.-L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332305 · Cited by 2,439
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., & Look, A. T. (1994) · Science · doi:10.1126/science.8122112 · Cited by 2,409
Wotherspoon, A. C., Diss, T. C., Pan, L., Isaacson, P. G., Doglioni, C., Moschini, A., & de Boni, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91409-f · Cited by 2,118
International T-Cell Lymphoma Project (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4558 · Cited by 2,108
Pfreundschuh, M., Trümper, L., Österborg, A., Pettengell, R., Trneny, M., Imrie, K., Ma, D., Gill, D., Walewski, J., Zinzani, P.-L., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70664-7 · Cited by 2,076
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,999
Stein, H., Mason, D., Gerdes, J., O'Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lemke, H., et al. (1985) · Blood · doi:10.1182/blood.v66.4.848.848 · Cited by 1,846
Maloney, D. G., Grillo-López, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T.-M., Dallaire, B. K., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2188 · Cited by 1,733
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
Wang, M. L., Rule, S., Martin, P., Goy, A., Auer, R., Kahl, B. S., Jurczak, W., Advani, R. H., Romaguera, J. E., Williams, M. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306220 · Cited by 1,685
Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665
Gisselbrecht, C., Glass, B., Mounier, N., Singh Gill, D., Linch, D. C., Trneny, M., Bosly, A., Ketterer, N., Shpilberg, O., Hagberg, H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.1618 · Cited by 1,625
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
Self-citationKochenderfer, J. N., Dudley, M. E., Kassim, S. H., Somerville, R. P. T., Carpenter, R. O., Stetler-Stevenson, M., Yang, J. C., Phan, G. Q., Hughes, M. S., Sherry, R. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2025 · Cited by 1,595
Rummel, M. J., Niederle, N., Maschmeyer, G., Banat, G. A., von Grünhagen, U., Losem, C., Kofahl-Krause, D., Heil, G., Welslau, M., Balser, C., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61763-2 · Cited by 1,510
Follicular lymphoma international prognostic index
Solal-Celigny, P. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0036-3 · Cited by 1,339
Armitage, J. O., & Weisenburger, D. D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2780 · Cited by 1,251
Self-citationWitzig, T. E., Gordon, L. I., Cabanillas, F., Czuczman, M. S., Emmanouilides, C., Joyce, R., Pohlman, B. L., Bartlett, N. L., Wiseman, G. A., Padre, N., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.076 · Cited by 1,170
Advani, R. H., Buggy, J. J., Sharman, J. P., Smith, S. M., Boyd, T. E., Grant, B., Kolibaba, K. S., Furman, R. R., Rodriguez, S., Chang, B. Y., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.7906 · Cited by 1,128
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Salles, G., Seymour, J. F., Offner, F., López-Guillermo, A., Belada, D., Xerri, L., Feugier, P., Bouabdallah, R., Catalano, J. V., Brice, P., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62175-7 · Cited by 1,079
Miller, T. P., Dahlberg, S., Cassady, J. R., Adelstein, D. J., Spier, C. M., Grogan, T. M., LeBlanc, M., Carlin, S., Chase, E., & Fisher, R. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390104 · Cited by 1,004
Lesokhin, A. M., Ansell, S. M., Armand, P., Scott, E. C., Halwani, A., Gutierrez, M., Millenson, M. M., Cohen, A. D., Schuster, S. J., Lebovic, D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.9789 · Cited by 1,001
Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia
Rai, K. R., Peterson, B. L., Appelbaum, F. R., Kolitz, J., Elias, L., Shepherd, L., Hines, J., Threatte, G. A., Larson, R. A., Cheson, B. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432402 · Cited by 1,001
Pro, B., Advani, R., Brice, P., Bartlett, N. L., Rosenblatt, J. D., Illidge, T., Matous, J., Ramchandren, R., Fanale, M., Connors, J. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0402 · Cited by 997
Sehn, L. H., Donaldson, J., Chhanabhai, M., Fitzgerald, C., Gill, K., Klasa, R., MacPherson, N., O'Reilly, S., Spinelli, J. J., Sutherland, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.137 · Cited by 987
Self-citationA new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Hoster, E., Dreyling, M., Klapper, W., Gisselbrecht, C., van Hoof, A., Kluin-Nelemans, H. C., Pfreundschuh, M., Reiser, M., Metzner, B., Einsele, H., et al. (2008) · Blood · doi:10.1182/blood-2007-06-095331 · Cited by 984
Bayerdörffer, E., Rudolph, B., Neubauer, A., Thiede, C., Lehn, N., Eidt, S., Stolte, M., & MALT Lyphoma Study Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)90113-2 · Cited by 959
Keating, M. J., Flinn, I., Jain, V., Binet, J.-L., Hillmen, P., Byrd, J., Albitar, M., Brettman, L., Santabarbara, P., Wacker, B., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3554 · Cited by 948
Zhou, Z., Sehn, L. H., Rademaker, A. W., Gordon, L. I., LaCasce, A. S., Crosby-Thompson, A., Vanderplas, A., Zelenetz, A. D., Abel, G. A., Rodriguez, M. A., et al. (2014) · Blood · doi:10.1182/blood-2013-09-524108 · Cited by 930
Self-citationKhouri, I. F., Keating, M., Körbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., Giralt, S., Ippoliti, C., von Wolff, B., Gajewski, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2817 · Cited by 919
Savage, K. J., Harris, N. L., Vose, J. M., Ullrich, F., Jaffe, E. S., Connors, J. M., Rimsza, L., Pileri, S. A., Chhanabhai, M., Gascoyne, R. D., et al. (2008) · Blood · doi:10.1182/blood-2008-01-134270 · Cited by 863
Self-citationCzuczman, M. S., Grillo-López, A. J., White, C. A., Saleh, M., Gordon, L., LoBuglio, A. F., Jonas, C., Klippenstein, D., Dallaire, B., & Varns, C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.268 · Cited by 856
Casulo, C., Byrtek, M., Dawson, K. L., Zhou, X., Farber, C. M., Flowers, C. R., Hainsworth, J. D., Maurer, M. J., Cerhan, J. R., Link, B. K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7534 · Cited by 850
The Risk of Lymphoma Development in Autoimmune Diseases: A Meta-analysis
Zintzaras, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.20.2337 · Cited by 771
Report on the First International Workshop on interim-PET scan in lymphoma
Meignan, M., Gallamini, A., Meignan, M., Gallamini, A., & Haioun, C. (2009) · Leukemia & Lymphoma · doi:10.1080/10428190903040048 · Cited by 754
Dierlamm, J., Baens, M., Wlodarska, I., Stefanova-Ouzounova, M., Hernandez, J. M., Hossfeld, D. K., De Wolf-Peeters, C., Hagemeijer, A., Van den Berghe, H., & Marynen, P. (1999) · Blood · doi:10.1182/blood.v93.11.3601 · Cited by 718
A breakpoint map of recurrent chromosomal rearrangements in human neoplasia
Mitelman, F., Mertens, F., & Johansson, B. (1997) · Nature Genetics · doi:10.1038/ng0497supp-417 · Cited by 698
Green, T. M., Young, K. H., Visco, C., Xu-Monette, Z. Y., Orazi, A., Go, R. S., Nielsen, O., Gadeberg, O. V., Mourits-Andersen, T., Frederiksen, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.4342 · Cited by 686
Anderson, J. R., Armitage, J. O., & Weisenburger, D. D. (1998) · Annals of Oncology · doi:10.1023/a:1008265532487 · Cited by 674
Self-citationO'Connor, O. A., Pro, B., Pinter-Brown, L., Bartlett, N., Popplewell, L., Coiffier, B., Jo Lechowicz, M., Savage, K. J., Shustov, A. R., Gisselbrecht, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.9024 · Cited by 647
Flinn, I. W., van der Jagt, R., Kahl, B. S., Wood, P., Hawkins, T. E., MacDonald, D., Hertzberg, M., Kwan, Y.-L., Simpson, D., Craig, M., et al. (2014) · Blood · doi:10.1182/blood-2013-11-531327 · Cited by 643
Shankland, K. R., Armitage, J. O., & Hancock, B. W. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60605-9 · Cited by 641
Self-citationFollicular Lymphoma International Prognostic Index
Solal-Celigny, P. (2004) · Blood · doi:10.1182/blood-2003-12-4434 · Cited by 626
Kaminski, M. S., Zelenetz, A. D., Press, O. W., Saleh, M., Leonard, J., Fehrenbacher, L., Lister, T. A., Stagg, R. J., Tidmarsh, G. F., Kroll, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.19.3918 · Cited by 584
Long-term survival in primary CNS lymphoma.
Abrey, L. E., DeAngelis, L. M., & Yahalom, J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.859 · Cited by 577
Lenz, G., Dreyling, M., Hoster, E., Wörmann, B., Dührsen, U., Metzner, B., Eimermacher, H., Neubauer, A., Wandt, H., Steinhauer, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.133 · Cited by 574
Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma
Dunleavy, K., Pittaluga, S., Maeda, L. S., Advani, R., Chen, C. C., Hessler, J., Steinberg, S. M., Grant, C., Wright, G., Varma, G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214561 · Cited by 569
O'Connor, O. A., Horwitz, S., Masszi, T., Van Hoof, A., Brown, P., Doorduijn, J., Hess, G., Jurczak, W., Knoblauch, P., Chawla, S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.2782 · Cited by 555
(2010) · The Lymphoid Neoplasms 3ed · doi:10.1201/b13424-40 · Cited by 540
Kwak, L. W., Campbell, M. J., Czerwinski, D. K., Hart, S., Miller, R. A., & Levy, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210223271705 · Cited by 533
Lenz, G., & Staudt, L. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0807082 · Cited by 528
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.
LoBuglio, A. F., Wheeler, R. H., Trang, J., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J., & Khazaeli, M. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4220 · Cited by 524
Treatment of Older Patients with Mantle-Cell Lymphoma
Kluin-Nelemans, H. C., Hoster, E., Hermine, O., Walewski, J., Trneny, M., Geisler, C. H., Stilgenbauer, S., Thieblemont, C., Vehling-Kaiser, U., Doorduijn, J. K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200920 · Cited by 520
Germinal centres and B cell lymphomagenesis
Basso, K., & Dalla-Favera, R. (2015) · Nature Reviews Immunology · doi:10.1038/nri3814 · Cited by 510
Foran, J. M., Rohatiner, A. Z. S., Cunningham, D., Popescu, R. A., Solal-Celigny, P., Ghielmini, M., Coiffier, B., Johnson, P. W. M., Gisselbrecht, C., Reyes, F., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.317 · Cited by 472
Parrilla Castellar, E. R., Jaffe, E. S., Said, J. W., Swerdlow, S. H., Ketterling, R. P., Knudson, R. A., Sidhu, J. S., Hsi, E. D., Karikehalli, S., Jiang, L., et al. (2014) · Blood · doi:10.1182/blood-2014-04-571091 · Cited by 472
Gianni, A. M., Bregni, M., Siena, S., Brambilla, C., Di Nicola, M., Lombardi, F., Gandola, L., Tarella, C., Pileri, A., Ravagnani, F., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705013361804 · Cited by 470
Petrich, A. M., Gandhi, M., Jovanovic, B., Castillo, J. J., Rajguru, S., Yang, D. T., Shah, K. A., Whyman, J. D., Lansigan, F., Hernandez-Ilizaliturri, F. J., et al. (2014) · Blood · doi:10.1182/blood-2014-05-578963 · Cited by 467
Spaepen, K., Stroobants, S., Dupont, P., Van Steenweghen, S., Thomas, J., Vandenberghe, P., Vanuytsel, L., Bormans, G., Balzarini, J., De Wolf-Peeters, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.414 · Cited by 465
Gisselbrecht, C., Gaulard, P., Lepage, É., Coiffier, B., Brière, J., Haïoun, C., Cazals-Hatem, D. L., Bosly, A., Xerri, L., Tilly, H., et al. (1998) · PubMed · doi:10.1182/blood.v92.1.76.413a19_76_82 · Cited by 437
Utility of FDG-PET scanning in lymphoma by WHO classification
Elstrom, R., Guan, L., Baker, G., Nakhoda, K., Vergilio, J.-A., Zhuang, H., Pitsilos, S., Bagg, A., Downs, L., Mehrotra, A., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2778 · Cited by 437
The French Cooperative Group on CLL, Johnson, S., Smith, A. G., Löffler, H., Ösby, E., Juliusson, G., Emmerich, B., Wyld, P. J., & Hiddemann, W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91681-5 · Cited by 434
Haioun, C., Lepage, E., Gisselbrecht, C., Salles, G., Coiffier, B., Brice, P., Bosly, A., Morel, P., Nouvel, C., Tilly, H., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.3025 · Cited by 421
Rüdiger, T., Weisenburger, D. D., Anderson, J. R., Armitage, J. O., Diebold, J., MacLennan, K. A., Nathwani, B. N., Ullrich, F., & Müller-Hermelink, H. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf033 · Cited by 419
Self-citationHermine, O., Hoster, E., Walewski, J., Bosly, A., Stilgenbauer, S., Thieblemont, C., Szymczyk, M., Bouabdallah, R., Kneba, M., Hallek, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00739-x · Cited by 400
Ardeshna, K. M., Qian, W., Smith, P., Braganca, N., Lowry, L., Patrick, P., Warden, J., Stevens, L., Pocock, C. F. E., Miall, F., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70027-0 · Cited by 395
Demidem, A., Lam, T., Alas, S., Hariharan, K., Hanna, N., & Bonavida, B. (1997) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1997.12.177 · Cited by 394
Leporrier, M., Chevret, S., Cazin, B., Boudjerra, N., Feugier, P., Desablens, B., Rapp, M., Jaubert, J., Autrand, C., Diviné, M., et al. (2001) · Blood · doi:10.1182/blood.v98.8.2319 · Cited by 391
Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
Robak, T., Huang, H., Jin, J., Zhu, J., Liu, T., Samoilova, O., Pylypenko, H., Verhoef, G., Siritanaratkul, N., Osmanov, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412096 · Cited by 386
Self-citationMolecular pathogenesis of mantle cell lymphoma
Jares, P., Colomer, D., & Campo, E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61272 · Cited by 382
New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma
Fisher, R. I., LeBlanc, M., Press, O. W., Maloney, D. G., Unger, J. M., & Miller, T. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1674 · Cited by 375
Howard, O. M., Gribben, J. G., Neuberg, D. S., Grossbard, M. L., Poor, C., Janicek, M. J., & Shipp, M. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1288 · Cited by 372
Dixon, D. O., Neilan, B., Jones, S. E., Lipschitz, D. A., Miller, T. P., Grozea, P. N., & Wilson, H. E. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.3.295 · Cited by 360
Low-Intensity Therapy in Adults with Burkitt's Lymphoma
Dunleavy, K., Pittaluga, S., Shovlin, M., Steinberg, S. M., Cole, D., Grant, C., Widemann, B., Staudt, L. M., Jaffe, E. S., Little, R. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1308392 · Cited by 360
Nowakowski, G. S., LaPlant, B., Macon, W. R., Reeder, C. B., Foran, J. M., Nelson, G. D., Thompson, C. A., Rivera, C. E., Inwards, D. J., Micallef, I. N., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.5714 · Cited by 359
Self-citationNon-Hodgkin's lymphoma time trends: United States and international data.
Devesa, S. S., & Fears, T. R. (1992) · PubMed · Cited by 355
Récher, C., Coiffier, B., Haioun, C., Molina, T. J., Fermé, C., Casasnovas, O., Thiéblemont, C., Bosly, A., Laurent, G., Morschhauser, F., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61040-4 · Cited by 355
Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma
Stiff, P. J., Unger, J. M., Cook, J. R., Constine, L. S., Couban, S., Stewart, D. A., Shea, T. C., Porcu, P., Winter, J. N., Kahl, B. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301077 · Cited by 343
Johnson, P. W., Rohatiner, A. Z., Whelan, J. S., Price, C. G., Love, S., Lim, J., Matthews, J., Norton, A. J., Amess, J. A., & Lister, T. A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.140 · Cited by 337
Morton, L. M., Slager, S. L., Cerhan, J. R., Wang, S. S., Vajdic, C. M., Skibola, C. F., Bracci, P. M., de Sanjose, S., Smedby, K. E., Chiu, B. C. H., et al. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu013 · Cited by 334
Self-citationGiordano, T. P., Henderson, L., Landgren, O., Chiao, E. Y., Kramer, J. R., El-Serag, H., & Engels, E. A. (2007) · JAMA · doi:10.1001/jama.297.18.2010 · Cited by 332
Wilson, W. H., Dunleavy, K. M., Pittaluga, S., Hegde, U. P., Grant, N., Steinberg, S. M., Raffeld, M. A., Gutierrez, M. E., Chabner, B. A., Staudt, L. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1391 · Cited by 326
Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication
Wündisch, T., Thiede, C., Morgner, A., Dempfle, A., Günther, A., Liu, H., Ye, H., Du, M.-Q., Kim, T. D., Bayerdörffer, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.3903 · Cited by 317
Differences in incidence and trends of haematological malignancies in Japan and the United States
Chihara, D., Ito, H., Matsuda, T., Shibata, A., Katsumi, A., Nakamura, S., Tomotaka, S., Morton, L. M., Weisenburger, D. D., & Matsuo, K. (2014) · British Journal of Haematology · doi:10.1111/bjh.12659 · Cited by 310
Pathogenesis of follicular lymphoma
Kridel, R., Sehn, L. H., & Gascoyne, R. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63186 · Cited by 310
Self-citationHoelzer, D., Walewski, J., Döhner, H., Viardot, A., Hiddemann, W., Spiekermann, K., Serve, H., Dührsen, U., Hüttmann, A., Thiel, E., et al. (2014) · Blood · doi:10.1182/blood-2014-03-563627 · Cited by 289
Crizotinib in Advanced, Chemoresistant Anaplastic Lymphoma Kinase–Positive Lymphoma Patients
Gambacorti Passerini, C., Farina, F., Stasia, A., Redaelli, S., Ceccon, M., Mologni, L., Messa, C., Guerra, L., Giudici, G., Sala, E., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt378 · Cited by 279
Vose, J. M., Armitage, J. O., Weisenburger, D. D., Bierman, P. J., Sorensen, S., Hutchins, M., Moravec, D. F., Howe, D., Dowling, M. D., & Mailliard, J. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.12.1838 · Cited by 272
Self-citationImaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
Newman, J. S., Francis, I. R., Kaminski, M. S., & Wahl, R. L. (1994) · Radiology · doi:10.1148/radiology.190.1.8259386 · Cited by 265
Vallisa, D., Bernuzzi, P., Arcaini, L., Sacchi, S., Callea, V., Marasca, R., Lazzaro, A., Trabacchi, E., Anselmi, E., Arcari, A. L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.008 · Cited by 263
Microsatellite instability in inherited and sporadic neoplasms
Eshleman, J. R., & Markowitz, S. D. (1995) · Current Opinion in Oncology · doi:10.1097/00001622-199501000-00013 · Cited by 262
Khan, A. B., Barrington, S. F., Mikhaeel, N. G., Hunt, A. A., Cameron, L., Morris, T., & Carr, R. (2013) · Blood · doi:10.1182/blood-2012-12-473389 · Cited by 246
Romaguera, J. E., Fayad, L. E., Feng, L., Hartig, K., Weaver, P., Rodriguez, M. A., Hagemeister, F. B., Pro, B., McLaughlin, P., Younes, A., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08228.x · Cited by 245
Müller, C., Murawski, N., Wiesen, M. H. J., Held, G., Poeschel, V., Zeynalova, S., Wenger, M., Nickenig, C., Peter, N., Lengfelder, E., et al. (2012) · Blood · doi:10.1182/blood-2011-09-380949 · Cited by 242
Buchmann, I., Reinhardt, M., Elsner, K., Bunjes, D., Altehoefer, C., Finke, J., Moser, E., Glatting, G., Kotzerke, J., Guhlmann, C. A., et al. (2001) · Cancer · doi:10.1002/1097-0142(20010301)91:5<889::aid-cncr1078>3.0.co;2-5 · Cited by 239
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma
Ruan, J., Martin, P., Shah, B., Schuster, S. J., Smith, S. M., Furman, R. R., Christos, P., Rodriguez, A., Svoboda, J., Lewis, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505237 · Cited by 236
Ghielmini, M., Vitolo, U., Kimby, E., Montoto, S., Walewski, J., Pfreundschuh, M., Federico, M., Hoskin, P., McNamara, C., Caligaris-Cappio, F., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds517 · Cited by 218
Wang, M. L., Lee, H., Chuang, H., Wagner-Bartak, N., Hagemeister, F., Westin, J., Fayad, L., Samaniego, F., Turturro, F., Oki, Y., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00438-6 · Cited by 216
Coiffier, B., Pro, B., Prince, H. M., Foss, F., Sokol, L., Greenwood, M., Caballero, D., Morschhauser, F., Wilhelm, M., Pinter-Brown, L., et al. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-11 · Cited by 212
Ghetie, M.-A., Bright, H., & Vitetta, E. S. (2001) · Blood · doi:10.1182/blood.v97.5.1392 · Cited by 191
Morton, L. M., Hartge, P., Holford, T. R., Holly, E. A., Chiu, B. C. H., Vineis, P., Stagnaro, E., Willett, E. V., Franceschi, S., La Vecchia, C., et al. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0693 · Cited by 187
Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody.
Mueller, B. M., Romerdahl, C. A., Gillies, S. D., & Reisfeld, R. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.4.1382 · Cited by 186
Mamot, C., Klingbiel, D., Hitz, F., Renner, C., Pabst, T., Driessen, C., Mey, U., Pless, M., Bargetzi, M., Krasniqi, F., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.9846 · Cited by 186
Ribrag, V., Koscielny, S., Bosq, J., Leguay, T., Casasnovas, O., Fornecker, L.-M., Recher, C., Ghesquieres, H., Morschhauser, F., Girault, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01317-3 · Cited by 185
The rise in incidence of lymphomas in Europe 1985–1992
Cartwright, R., Brincker, H., Carli, P. M., Clayden, D., Coebergh, J. W., Jack, A., McNally, R., Morgan, G., de Sanjose, S., Tumino, R., et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00401-8 · Cited by 183
Trotman, J., Luminari, S., Boussetta, S., Versari, A., Dupuis, J., Tychyj, C., Marcheselli, L., Berriolo-Riedinger, A., Franceschetto, A., Julian, A., et al. (2014) · The Lancet Haematology · doi:10.1016/s2352-3026(14)70008-0 · Cited by 182
The role of positron emission tomography (PET) in the management of lymphoma patients
Zinzani, P. L., Magagnoli, M., Chierichetti, F., Zompatori, M., Garraffa, G., Bendandi, M., Gherlinzoni, F., Cellini, C., Stefoni, V., Ferlin, G., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008327127033 · Cited by 180
Leonard, J. P., Jung, S.-H., Johnson, J., Pitcher, B. N., Bartlett, N. L., Blum, K. A., Czuczman, M., Giguere, J. K., & Cheson, B. D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.9258 · Cited by 180
Familial predisposition and genetic risk factors for lymphoma
Cerhan, J. R., & Slager, S. L. (2015) · Blood · doi:10.1182/blood-2015-04-537498 · Cited by 178
Utility of Routine Post-Therapy Surveillance Imaging in Diffuse Large B-Cell Lymphoma
Thompson, C. A., Ghesquieres, H., Maurer, M. J., Cerhan, J. R., Biron, P., Ansell, S. M., Chassagne-Clément, C., Inwards, D. J., Gargi, T., Johnston, P. B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.7561 · Cited by 175
Changing incidence of non‐Hodgkin lymphomas in the United States
Clarke, C. A., & Glaser, S. L. (2002) · Cancer · doi:10.1002/cncr.10403 · Cited by 173
Anderson, J. R., Jenkin, R. D., Wilson, J. F., Kjeldsberg, C. R., Sposto, R., Chilcote, R. R., Coccia, P. F., Exelby, P. R., Siegel, S., & Meadows, A. T. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1024 · Cited by 170
Cerhan, J. R., Berndt, S. I., Vijai, J., Ghesquières, H., McKay, J., Wang, S. S., Wang, Z., Yeager, M., Conde, L., de Bakker, P. I. W., et al. (2014) · Nature Genetics · doi:10.1038/ng.3105 · Cited by 170
Spaepen, K., Stroobants, S., Dupont, P., Thomas, J., Vandenberghe, P., Balzarini, J., De Wolf‐Peeters, C., Mortelmans, L., & Verhoef, G. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03169.x · Cited by 169
Ferreri, A. J. M., Govi, S., Pasini, E., Mappa, S., Bertoni, F., Zaja, F., Montalbán, C., Stelitano, C., Cabrera, M. E., Giordano Resti, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.4466 · Cited by 168
Self-citationWilson, W. H., Jung, S.-H., Porcu, P., Hurd, D., Johnson, J., Martin, S. E., Czuczman, M., Lai, R., Said, J., Chadburn, A., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.056531 · Cited by 167
Non-Hodgkin’s Lymphomas, Version 4.2014
Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0125 · Cited by 166
Rummel, M., Kaiser, U., Balser, C., Stauch, M. B., Brugger, W., Welslau, M., Niederle, N., Losem, C. J., Böck, H.-P., Weidmann, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00447-7 · Cited by 162
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32
Conde, L., Halperin, E., Akers, N. K., Brown, K. M., Smedby, K. E. E., Rothman, N., Nieters, A., Slager, S. L., Brooks-Wilson, A. R., Agana, L., et al. (2010) · Nature Genetics · doi:10.1038/ng.626 · Cited by 158
Trněný, M., Lamy, T., Walewski, J. A., Belada, D., Mayer, J., Radford, J. A., Jurczak, W. J., Morschhauser, F., Alexeeva, J., Rule, S. A., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00559-8 · Cited by 156
Liu, A. Y. C., Robinson, R. R., Murray, E., Ledbetter, J. A., Hellström, I., & Hellström, K. E. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.10.3521 · Cited by 140
Kaiser, U., Uebelacker, I., Abel, U. R., Birkmann, J., Trümper, L. H. P., Schmalenberg, H., Karakas, T., Metzner, B., HOSSFELD, D. K., Bischoff, H. G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.075 · Cited by 139
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis
Morton, L. M., Zheng, T., Holford, T. R., Holly, E. A., Chiu, B. C. ‐., Costantini, A. S., Stagnaro, E., Willett, E. V., Maso, L. D., Serraino, D., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70214-x · Cited by 134
Maddocks, K. J., Christian, B. A., Jaglowski, S. M., Flynn, J. M., Jones, J. A., Porcu, P., Wei, L., Jenkins, C., Lozanski, G., Byrd, J. C., et al. (2014) · Blood · doi:10.1182/blood-2014-08-597914 · Cited by 133
Fenske, T. S., Ahn, K. W., Graff, T. M., Digilio, A., Bashir, Q., Kamble, R. T., Ayala, E., Bacher, U., Brammer, J. E., Cairo, M. S., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14046 · Cited by 133
Lenz, G., Dreyling, M. H., Schiegnitz, E., Haferlach, T., Hasford, J., Unterhalt, M., & Hiddemann, W. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.016 · Cited by 130
Evans, L., & Hancock, B. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13868-8 · Cited by 127
Byrd, J. C., Jones, J. J., Woyach, J. A., Johnson, A. J., & Flynn, J. M. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.8262 · Cited by 119
Shiels, M. S., Engels, E. A., Linet, M. S., Clarke, C. A., Li, J., Hall, H. I., Hartge, P., & Morton, L. M. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0040 · Cited by 112
Personal Use of Hair Dye and the Risk of Certain Subtypes of Non-Hodgkin Lymphoma
Zhang, Y., Sanjosé, S. D., Bracci, P. M., Morton, L. M., Wang, R., Brennan, P., Hartge, P. A., Boffetta, P., Becker, N., Maynadié, M., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn058 · Cited by 108
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
Touroutoglou, N., Dimopoulos, M. A., Younes, A. I. A., Hess, M., Pugh, W. C., Cox, J. D., Cabanillas, F., & Sarris, A. H. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1361 · Cited by 105
New Approaches to Lymphoma Diagnosis
Harris, N. L., Stein, H., Coupland, S. E., Hummel, M., Favera, R. D., Pasqualucci, L., & Chan, W. C. (2001) · Hematology · doi:10.1182/asheducation-2001.1.194 · Cited by 102
Rizzieri, D. A., Johnson, J. L., Byrd, J. C., Lozanski, G., Blum, K. A., Powell, B. L., Shea, T. C., Nattam, S. R., Hoke, E. E., Cheson, B. D., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12736 · Cited by 99
B-cell non-Hodgkin lymphoma linked to Coxiella burnetii
Melenotte, C., Million, M., Audoly, G., Gorse, A., Dutronc, H., Roland, G., Dekel, M., Moreno, A., Cammilleri, S., Carrieri, P., et al. (2015) · Blood · doi:10.1182/blood-2015-04-639617 · Cited by 98
Interpretation of clinical trials in diffuse large-cell lymphoma.
Armitage, J. O., & Cheson, B. D. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.8.1335 · Cited by 97
Self-citationHow I treat Burkitt lymphoma in adults
Jacobson, C. A., & LaCasce, A. S. (2014) · Blood · doi:10.1182/blood-2014-06-538504 · Cited by 96
I. Epidemiology of adult non-Hodgkin lymphoma
Boffetta, P. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr167 · Cited by 96
El‐Galaly, T. C., Jakobsen, L. H., Hutchings, M., Brown, P. D. N., Nilsson‐Ehle, H., Székely, E., Mylam, K. J., Hjalmar, V., Johnsen, H. E., Bøgsted, M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.0229 · Cited by 94
Molina, T. J., Canioni, D., Copie‐Bergman, C., Récher, C., Brière, J., Haïoun, C., Berger, F., Fermé, C., Copin, M., Casasnovas, O., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.9493 · Cited by 94
Clinicopathologic Correlations of Genomic Gains and Losses in Follicular Lymphoma
Viardot, A., Mӧller, P., Högel, J., Werner, K., Mechtersheimer, G., Ho, A. D., Ott, G., Barth, T. F. E., Siebert, R., Gesk, S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.006 · Cited by 93
Landsburg, D. J., Petrich, A. M., Abramson, J. S., Sohani, A. R., Press, O. W., Cassaday, R. D., Chávez, J. C., Song, K., Zelenetz, A. D., Gandhi, M. D., et al. (2015) · Cancer · doi:10.1002/cncr.29781 · Cited by 87
Diffuse Large B-Cell Lymphoma Version 1.2016
Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N. L., Byrd, J. C., Fayad, L., Fisher, R. I., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0023 · Cited by 87
Self-citationIncidence and mortality from non‐Hodgkin lymphoma in Europe: The end of an epidemic?
Bosetti, C., Levi, F., Ferlay, J., Lucchini, F., Negri, E., & Vecchia, C. L. (2008) · International Journal of Cancer · doi:10.1002/ijc.23722 · Cited by 78
Chang, E. T., Canchola, A. J., Cockburn, M., Lu, Y., WANG, S. S., Bernstein, L., Clarke, C. A., & Horn‐Ross, P. L. (2011) · Blood · doi:10.1182/blood-2011-02-336065 · Cited by 71
Microsatellite instability is rare in B-cell non-Hodgkin's lymphomas.
Gamberi, B., Gaïdano, G., Parsa, N. Z., Carbone, A., Roncella, S., Knowles, D. M., Louie, D. C., Shibata, D. K., Chaganti, R. S. K., & Dalla‐Favera, R. (1997) · PubMed · doi:10.1182/blood.v89.3.975 · Cited by 67
WANG, S. S., Flowers, C. R., Kadin, M. E., Chang, E. T., Hughes, A. M., Ansell, S. M., Feldman, A. L., Lightfoot, T., Boffetta, P., Melbye, M., et al. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu012 · Cited by 65
Castillo, J. J., Ingham, R. R., Reagan, J. L., Furman, M. S., Dalia, S. M., & Mitri, J. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.10.005 · Cited by 54
SnapShot: Diffuse Large B Cell Lymphoma
Pasqualucci, L., & Dalla‐Favera, R. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.012 · Cited by 49
What treatment for elderly patients with aggressive lymphoma?
Ciffier, B. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058722 · Cited by 38
Davis, T. A., Hsu, F. J., Caspar, C. B., van Beckhoven, A., Czerwinski, D. K., Liles, T. M., Taidi, B., Benike, C. J., Engleman, E. G., & Levy, R. (2001) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2001.v7.pm11669219 · Cited by 36
van de Schans, S. A. M., Issa, D. E., Visser, O. J., Nooijen, P. T. G. A., Huijgens, P. C., Karim‐Kos, H. E., Janssen-Heijnen, M. L. G., & Coebergh, J. W. W. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr055 · Cited by 31
Oh, D. H. J., Li, H., Duan, Q., Villa, D. R., Peters, A., Chua, N. S., Owen, C., Connors, J. M., & Stewart, D. A. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.01.015 · Cited by 7
Cited by
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Gopal, A. K., Kahl, B. S., de Vos, S., Wagner-Johnston, N. D., Schuster, S. J., Jurczak, W. J., Flinn, I. W., Flowers, C. R., Martin, P., Viardot, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314583 · Cited by 1,069
Schofer, J., Schlüter, M., Gershlick, A. H., Wijns, W., Garcia, E., Schampaert, E., & Breithardt, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14462-5 · Cited by 955
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Jiang, N., Dai, Q., Su, X., Fu, J., Feng, X., & Peng, J. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05435-1 · Cited by 571
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Zhang, L., Rana, I., Shaffer, R. M., Taioli, E., & Sheppard, L. (2019) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2019.02.001 · Cited by 374
Metadata
- Authors
- Armitage, J. O., Gascoyne, R. D., Lunning, M. A., & Cavalli, F.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 390
- Issue
- 10091
- Pages
- 298-310
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2050115670
- Cited by
- 1,176
- References
- 165
- FWCI
- 58.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.